Company Description

Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye.

The company's delivery technology penetrates the skin and nails and reduces antibiotic resistance through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses.

The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025.

Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.

Turn Therapeutics Inc.

Country	United States
Founded	2015
Industry	Biotechnology
Sector	Healthcare
CEO	Bradley Burnam

Contact Details

Address: 250 N Westlake Blvd Westlake Village, California 91362 United States
Phone	818 546 4011
Website	turntherapeutics.com

Stock Details

Ticker Symbol	TTRX
Exchange	NASDAQ
Fiscal Year	January - December
Reporting Currency	USD
CIK Code	2023016
CUSIP Number	90021W105
ISIN Number	US90021W1053
Employer ID	32-0456090
SIC Code	2834

Key Executives

Name	Position
Bradley E. Burnam	Founder, Chief Executive Officer and Director
Dr. Neilesh Shailesh Ghodadra M.D.	Chief Medical Officer and Director
Zuraiz Chaudhary	Interim Chief Financial Officer, Vice President of Finance and Chief Accounting Officer
Mohammed Zubair	Controller

Latest SEC Filings

Date	Type	Title
Apr 6, 2026	SCHEDULE 13G	Filing
Apr 2, 2026	EFFECT	Notice of Effectiveness
Apr 2, 2026	EFFECT	Notice of Effectiveness
Mar 31, 2026	POS AM	Post-Effective amendments for registration statement
Mar 31, 2026	POS AM	Post-Effective amendments for registration statement
Mar 31, 2026	10-K	Annual Report
Mar 31, 2026	8-K	Current Report
Mar 24, 2026	8-K	Current Report
Feb 17, 2026	8-K	Current Report
Feb 9, 2026	8-K	Current Report

View All SEC Filings